期刊文献+

自杀基因治疗恶性胶质瘤的研究 被引量:2

Study on Suicide Gene Therapy of Malignant Glioma
下载PDF
导出
摘要 目的:单纯疱疹病毒Ⅰ型胸苷激酶(HSV-tk)基因治疗恶性胶质瘤体内外试验。方法:分子克隆及真核细胞基因转染技术构建逆转录病毒(RV)载体pMV7(tk)及PA317tk包装细胞系;体外不同比例混合鼠C6胶质瘤细胞与PA317tk细胞,在GCV(Ganciclovir)作用下观察细胞存活率;建立SD大鼠颅内C6胶质瘤模型(种植5×105C6细胞),治疗组第3天原位注射5×106PA317tk细胞,5天后腹腔给予GCV(30mg/kg.d),MRI全程监测肿瘤消长,观察病症及存活期,并行病理检查。结果:在GCV0.1~101μg/ml浓度范围内,C6细胞存活率随PA317tk细胞混入比例增加而逐渐减低(P<0.001),并具有GCV剂量依赖性(P<0.01);体内试验治疗组病症轻,生存期延长,MRI表明治疗组肿瘤体积较对照组明显减小(P<0.01),1个月时病理检查见肿瘤细胞消失,代之以小胶质细胞增生并形成坏死囊。结论:应用本实验室构建的RV载体pMV7(tk)及其PA317tk包装细胞系治疗恶性胶质瘤是一种有效及具有前途的治疗方法。 Objective: To study the effects of Herpes Simplex virus type 1 thymidine kinase (HSV-tk) gene and Ganciclovir (GCV)therapeutic system for malignant glioma in vitro and in vivo Methods: We constructed retrovirus (RV) vector bearing HSV-tk gene and established its packaging cell line PA317tk using the technique of molecular cloning and gene transfection for eukaryotic cells respectively; C6 glioma cells were mixed with PA317tk cells in various percentages and exposed to GCV in vitro, cell survival rate was determined with MTT method; C6 glioma model in vivo was established in SD rat (5105 C6 cells xenograft);5106 PA317tk cells were injected in situ on the third day after tumor cells xenograft GCV was administrated ip at the dose of 30mg/kg/day 5 days later Tumor growth or regression was monitored with MRI General manifestation after implantation with C6 glioma cells, survival time and pathological examination were also observed Results: Survival rate of C6 cells was negatively correlated with the percentage of PA317tk cells added (P< 0001), and its reduction was GCV dose dependent (P< 001) Milder symptomatic manifestation, longer survival and smaller tumor volume were obvious in the treatment group as compared to the control group Tumor cells almost disappeared and were replaced with the proliferation of glial cells and the formation of necrotic cyst Conclusion: The treatment of glioma using RV vector pMV7 (tk) and its packaging cell line PA317tk constructed and established in our laboratory is an effective and prospective modality of treatment
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1999年第6期405-408,共4页 Chinese Journal of Clinical Oncology
关键词 胶质瘤 自杀基因 MRI监测 治疗 Suicide gene MRI monitoring Glioma
  • 相关文献

参考文献4

二级参考文献4

  • 1Lang F F,J Neurosurg,1994年,81卷,427页
  • 2Chen S H,Proc Natl Acad Sci USA,1994年,91卷,3054页
  • 3Chou J,Proc Natl Acad Sci USA,1992年,89卷,326页
  • 4Chou J,Science,1990年,250卷,1262页

共引文献5

同被引文献23

  • 1[4]Benedetti S, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med, 2000, 6:447450.
  • 2[6]Markert JM, Parker JN, Gillespie GY, et al. Genetically engineered human herpes simplex virus in the treatment of brain tumours. Herpes, 2001, 8:17-22.
  • 3[7]Samoto K, Ehtesham M, Perng GC, et al. A herpes simplex virus type 1 mutant with gamma 34.5 and LAT deletions effectively oncolyses human U87 glioblastomas in nude mice. Neurosurgery, 2002, 50:599-605.
  • 4[8]Nanda D, Vogels R, Havenga M, et al. Treatment of malignantgliomas with a replicating adenoviral vector expressing herpes sim plex virus-thymidine kinase. Cancer Res, 2001, 61:8743-8750.
  • 5[9]Zhang Y, Jeong Lee H, Boado RJ, et al. Receptor-mediated delivery of an antisense gene to human brain cancer cells. J Gene Med, 2002, 4:183-194.
  • 6[10]Miller CR, Williams CR, Buchsbaum DJ, et al. Intratumoral 5-fluo rouracil produced by cytosine deaminase/5-fluorocytosine gene ther apy is effective for experimental human glioblastomas. Cancer Res, 2002, 62:773-780.
  • 7[11]Ichikawa T, Tamiya T, Adachi Y, et al. In vivo efficacy and toxicityof 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther, 2000, 7:74-82.
  • 8[12]Sanson M, Marcaud V, Robin E, et al. Connexin 43-mediated bystander effect in two rat glioma cell models. Cancer Gene Ther, 2002, 9:149-155.
  • 9[13]Namba H, Iwadate Y, Kawamura K, et al. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells. Cancer Gene Ther, 2001, 8:414-420.
  • 10[14]Mayo LD, Dixon JE, Durden DL, et al. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem, 2002, 277:5484-5489.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部